Retatrutide Supply Register

Sources, Formats, Prices

A gloved healthcare professional prepares a syringe next to a small glass vial on a clean surface.

Single-Dose vs Multi-Dose Retatrutide Vial Formats Compared

A comparison of single-dose and multi-dose retatrutide vial formats, covering fill volume, concentration labeling, reconstitution math, and how listings present each option.

Reviewed by James Okafor, PharmD, clinical pharmacist ·

James Okafor, PharmD is a clinical pharmacist with 10 years of experience in academic hospital and specialty compounding environments, with expertise in peptide reconstitution, pharmaceutical stability, and storage protocols.

  • retatrutide
  • vial-formats
  • reconstitution
  • comparison

Retatrutide listings are packaged in two distinct ways: single-dose vials meant to be used once and discarded, and multi-dose vials designed for repeated withdrawals over time. The difference is not just container size. It changes how a listing states concentration, how reconstitution math is set up, and how a vendor documents stability after the vial is first opened.

What “single-dose” and “multi-dose” mean on a listing

A single-dose vial is packaged and typically capped with the expectation that the entire contents are drawn in one session shortly after reconstitution. Listings for single-dose formats often show a single total mg amount per vial with no explicit statement about post-reconstitution shelf life, because the format assumes near-immediate use.

A multi-dose vial holds the same kind of lyophilized peptide but is labeled and, in many cases, stoppered in a way intended to tolerate multiple needle entries over a period of days or weeks. Listings for multi-dose formats more often include a stated storage window after reconstitution, since the vial is expected to sit in a refrigerator between withdrawals rather than being emptied right away.

Neither label changes what is inside the vial chemically. The distinction is about intended handling, not potency or purity, and research-use listings should not imply otherwise.

Reading the two formats side by side

AttributeSingle-dose vialMulti-dose vial
Intended use patternOne withdrawal, then discardedMultiple withdrawals over time
Listing typically statesTotal mg per vialTotal mg per vial, sometimes concentration per mL
Post-reconstitution guidanceOften absent (assumes immediate use)More often stated, since the vial is reopened
Stopper accessMay be entered onceDesigned for repeated needle entry
Common vial sizes seen in listings2 mg, 5 mg, 10 mg5 mg, 10 mg, 15 mg, 20 mg

The sizes above reflect what commonly appears across listings and vary by vendor; they are not a fixed industry standard.

Why concentration math looks different between the two

Concentration is calculated the same way regardless of format: vial mg divided by the mL of bacteriostatic water added. What changes is how a listing frames the number. A single-dose listing frequently states only the mg total, leaving concentration for the buyer to compute once a reconstitution volume is chosen. A multi-dose listing is more likely to state a target concentration directly, since that concentration needs to stay consistent across several withdrawals for the per-dose math to hold.

Worked example: a 10 mg vial reconstituted with 2 mL of bacteriostatic water.

Concentration = 10 mg / 2 mL = 5 mg/mL.

Converted to mcg for a U-100 insulin syringe: 5 mg/mL equals 5000 mcg/mL. Since 1 mL on a U-100 syringe corresponds to 100 units, each unit drawn on the syringe represents 5000 mcg ÷ 100 = 50 mcg.

If the same 10 mg vial were instead reconstituted with 5 mL, the concentration drops to 10 mg / 5 mL = 2 mg/mL, or 2000 mcg/mL, meaning each unit on a U-100 syringe would represent 2000 mcg ÷ 100 = 20 mcg. This is the calculation multi-dose listings are implicitly relying on when they state a fixed concentration: the reconstitution volume has to stay the same across the vial’s life, or the mcg-per-unit figure a buyer worked out on day one stops matching reality on day ten. For readers who want to check this kind of arithmetic against their own numbers, a reconstitution calculator like the one at peptcalc.com can cross-check the mg-to-mL-to-unit conversion.

What listings tend to disclose, and what they leave out

Single-dose listings tend to be simpler because there is less to track: mg per vial, lot or batch identifier if provided, and a coa reference where available. There is usually no discussion of how long the reconstituted solution remains viable, because the format is not designed to be revisited.

Multi-dose listings carry more information because more can go wrong across repeated use. A well-documented multi-dose listing states the intended reconstitution volume, the resulting concentration, and a refrigerated storage window after mixing. Some also note how the vial should be handled between withdrawals, such as returning it to refrigeration promptly. A listing that omits this information but still markets the product as multi-dose is providing less detail than the format calls for.

Buyers comparing sources for a single-dose vs multi-dose retatrutide vial format decision are often really comparing how much handling information each listing provides, not just the vial size. Vendors that maintain a structured catalogue across multiple compounds, such as the listing pages HEEZ Research maintains for its research peptide lineup, tend to standardize this kind of disclosure across products rather than varying it listing to listing.

Price framing differs between the two formats

Because multi-dose vials are usually larger in total mg, their listed price per vial is typically higher, but the price per mg can be lower than an equivalent single-dose vial from the same source. This is arithmetic, not a claim about value: a 20 mg multi-dose vial priced at a given total will show a lower cost per mg than a 5 mg single-dose vial priced at a proportionally similar rate, simply because fixed packaging and handling costs are spread across more total peptide. Comparing price per mg rather than price per vial is the more consistent way to line up single-dose and multi-dose options from the same or different vendors.

Summary

Single-dose and multi-dose retatrutide vials contain the same underlying material; the difference is in intended handling, how listings present concentration information, and how much post-reconstitution detail a vendor discloses. Single-dose formats favor simplicity and immediate use, while multi-dose formats require listings to be explicit about reconstitution volume and storage window so the concentration math stays consistent across multiple withdrawals. Reading a listing’s disclosure level, not just its vial size, is the more reliable way to judge how well-documented a given format is.

← All articles